The global decrease in cancer mortality: trends and disparities
D Hashim, P Boffetta, C La Vecchia, M Rota, P Bertuccio, M Malvezzi, E Negri, D Hashim, P Boffetta, C La Vecchia, M Rota, P Bertuccio, M Malvezzi, E Negri
Abstract
Background: A decrease in cancer mortality has been reported in the United States, Europe, and other high-income regions during the last two decades. Whether similar trends apply to low-to-middle income countries-and globally-is unclear.
Design: The aim of this descriptive study is to compare cancer mortality in all countries with high- or intermediate-quality data on death certificates according to the World Health Organization (WHO) mortality database for the years 2000 through 2010. We included 60 countries in the analysis and calculated age-adjusted mortality rates for all cancer combined and for the commonest cancers worldwide: lung, stomach, breast, colorectal, uterine, and prostate.
Results: A decrease in overall cancer mortality rate of ∼1% per year was observed in higher and lower income regions and in both sexes. In 2010, 696 000 cancer deaths were avoided on a global scale compared with 2000 rates (426 000 in men, 271 000 in women). However, the mortality of liver cancer in both sexes and lung cancer in females increased in many countries'.
Conclusions: The individual risk of dying from cancer decreased in all countries with reliable data. This decrease was chiefly due to favorable trends in the commonest specific cancers. Liver cancer in both sexes and lung cancer in women, which show increasing mortality rates, constitute a priority for prevention and further research.
Keywords: cancer; data collection/standards; global health; mortality; registries/standards; vital statistics.
© The Author 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Source: PubMed
Prochains essais cliniques
-
Assiut UniversityPas encore de recrutement
-
Beijing Tiantan HospitalPas encore de recrutementAVC ischémique aigu | Occlusion des gros vaisseauxChine
-
Cumhuriyet UniversityPas encore de recrutementDouleur post-opératoire, aiguë | Mastectomie radicale modifiée | Blocs d'avion facialTurquie (Türkiye)
-
Mayo ClinicRoche Pharma AG; Advanced Research Projects Agency for HealthPas encore de recrutement
-
The First Affiliated Hospital of Soochow UniversityRecrutementAcute Myeloid LeukemaChine
-
IRCCS San RaffaeleAzienda Ospedaliero-Universitaria Maggiore della Carità di Novara; Ospedale... et autres collaborateursPas encore de recrutement
-
Lisa SatterAbbVie; National Center for Advancing Translational Sciences (NCATS)Pas encore de recrutementJAK1 GOF | STAT1 GOF | STAT3 GOF | STAT5B GOF | STAT6 GOFÉtats-Unis
-
Sichuan Academy of Medical SciencesRecrutementNeuronal Intranuclear Inclusion Disease (NIID)Chine
-
Tianjin Medical University Cancer Institute and...Pas encore de recrutementPatients With Low HER2 Expression (IHC 1+ or IHC 2+/ISH-) and HER2 IHC 0 Advanced Breast Cancer
-
Akiva CohenPas encore de recrutementCommotion cérébrale | Commotion cérébrale, cerveau | MTBI - Lésion cérébrale traumatique légère | Commotion cérébrale (diagnostic)
-
Izmir Bakircay UniversityRecrutementChemotherapy-Related Taste AlterationTurquie (Türkiye)
-
Centre Mohammed VI de la Recherche et de l'Innovation...RecrutementInteraction Médicament Alimentaire | Cancer (tumeurs solides)Maroc